MOHD MALIK: Open Payments
NPI 1942208715 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,017 in 28 payments from 7 companies in 2025. Trend: 2023 $281,428 · 2024 $35,709 · 2025 $1,017
Food & beverage: $1,017
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $548 |
| Neuronetics, Inc. | 3 | $246 |
| Lundbeck LLC | 1 | $93 |
| Alkermes, Inc. | 2 | $56 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
Products named: CAPLYTA, NEUROSTAR TMS THERAPY SYSTEM, REXULTI, ARISTADA, Qelbree, Auvelity, INVEGA SUSTENNA.
Industry payments across MO — which companies pay providers there.
